Thu, July 22, 2021
Wed, July 21, 2021
Tue, July 20, 2021
Mon, July 19, 2021
Fri, July 16, 2021
Thu, July 15, 2021
Wed, July 14, 2021
Tue, July 13, 2021
Mon, July 12, 2021

David Lebowitz Maintained (ARQT) at Buy with Decreased Target to $50 on, Jul 16th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-50-on-jul-16th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

David Lebowitz of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Decreased Target from $52 to $50 on, Jul 16th, 2021.

David has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Uy Ear of "Mizuho" Initiated at Strong Buy and Held Target at $58 on, Wednesday, June 30th, 2021

Publication Contributing Sources